Komori
Advanex (5998) · FactDecrease in R&D expenses

R&D expenditure

First written in FY2017-Q2. 4 of 33 entries say "Restated". Latest entry: FY2026.

33entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q2 – FY20262016: 12017: 420172018: 420182019: 320192020: 420202021: 420212022: 420222023: 420232024: 320242025: 120252026: 12026
Same theme, other companies
Decline in R&D Expenses with No Change in Activity StatusA theme 43 companies write about · 18 as a headwind · 10 as a tailwind

26 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 43 companies compared. The sentences above are computed from all 43.
Full recordFilings, disclosures and news, newest first
  1. FY2026Decrease in R&D expensesAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥188.867 million, with R&D expenses by segment as follows.」

    R&D expenses decreased from ¥220.917 million in the previous fiscal year to ¥188.867 million. R&D activities for the automotive, medical and housing-equipment markets in Japan and automotive factory automation in Asia continued.
  2. FY2025R&D spending increasedAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥220.917 million, with R&D expenses by segment as follows.」

    R&D expenses increased from ¥185.941 million in the previous fiscal year to ¥220.917 million. R&D expenses were recorded for the automotive, medical and housing-equipment markets in Japan and for automotive factory automation in Asia.
  3. FY2025-H1R&D spending increasedAnnual report

    「Total R&D expenses for the six-month consolidated accounting period amounted to ¥107.933 million.」

    R&D expenses amounted to ¥107.933 million, up from ¥95.242 million in the same period of the previous year.
  4. FY2024Increase in cash outflowsAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥185.941 million, with R&D expenses by segment as follows.」

    R&D expenses increased from ¥110.596 million in the previous fiscal year to ¥185.941 million. R&D expenses were recorded for the automotive, medical and housing-equipment markets in Japan and for factory automation in Asia.
  5. FY2024-Q3Increase in cash outflowsAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥145.878 million.」

    R&D expenses amounted to ¥145.878 million, up from ¥63.142 million in the same period of the previous year.
  6. FY2024-Q2Increase in cash outflowsAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year amounted to ¥95.242 million.」

    R&D expenses amounted to ¥95.242 million, up from ¥39.539 million in the same period of the previous year.
  7. FY2024-Q1Increase in cash outflowsAnnual report

    「Total R&D expenses for the first three months of the current consolidated fiscal year amounted to ¥45.406 million.」

    R&D expenses amounted to ¥45.406 million, up from ¥19.079 million in the first quarter of the previous fiscal year.
  8. FY2023Increase in cash outflowsAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥110.596 million, with R&D expenses by segment as follows.」

    R&D expenses increased from ¥68.113 million in the previous fiscal year to ¥110.596 million. R&D expenses were recorded for the automotive, medical and housing-equipment markets in Japan and for automation in Asia.
  9. FY2023-Q3Increase in cash outflowsAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥63.142 million.」

    R&D expenses increased from ¥49.610 million in the same period of the previous year to ¥63.142 million.
  10. FY2023-Q2Decrease in R&D expensesAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year amounted to ¥39.539 million.」

    R&D expenses decreased from ¥61.544 million in the same period of the previous year to ¥39.539 million.
  11. FY2023-Q1Decrease in R&D expensesAnnual report

    「Total R&D expenses for the first three months of the current consolidated fiscal year amounted to ¥19.079 million.」

    R&D expenses decreased from ¥30.280 million in the same period of the previous year to ¥19.079 million.
  12. FY2022Decrease in R&D expensesAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥68.113 million, with R&D expenses by segment as follows.」

    R&D expenses decreased from ¥72.220 million in the previous fiscal year to ¥68.113 million. R&D activities related to precision metal processing, molding, assembly, productivity improvement and other areas continued.
  13. FY2022-Q3Decrease in R&D expensesAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥49.610 million.」

    R&D expenses decreased from ¥93.320 million in the same period of the previous year to ¥49.610 million.
  14. FY2022-Q2Decrease in R&D expensesAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year amounted to ¥31.825 million.」

    R&D expenses decreased from ¥61.544 million in the same period of the previous year to ¥31.825 million.
  15. FY2022-Q1Decrease in R&D expensesAnnual report

    「Total R&D expenses for the first three months of the current consolidated fiscal year amounted to ¥15.842 million.」

    R&D expenses decreased from ¥30.280 million in the same period of the previous year to ¥15.842 million.
  16. FY2021Decrease in R&D expensesAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥72.220 million, with R&D expenses by segment as follows.」

    R&D expenses decreased from ¥146.952 million in the previous fiscal year to ¥72.220 million. Activities related to precision metal processing, molding, assembly, productivity improvement and other areas continued.
  17. FY2021-Q3Decrease in R&D expensesAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥93.320 million.」

    R&D expenses decreased from ¥110 million in the same period of the previous year to ¥93.320 million.
  18. FY2021-Q2Decrease in expendituresAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year amounted to ¥61.544 million.」

    R&D expenses decreased from ¥76.448 million in the same period of the previous year to ¥61.544 million. No significant changes to the R&D activities themselves were disclosed.
  19. FY2021-Q1Decrease in expendituresAnnual report

    「Total R&D expenses for the first three months of the current consolidated fiscal year amounted to ¥30.280 million.」

    R&D expenses decreased from ¥38.504 million in the same period of the previous year to ¥30.280 million. No significant changes to the R&D activities themselves were disclosed.
  20. FY2020Increase in cash outflowsAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥146.952 million, with R&D expenses by segment as follows.」

    Full-year R&D expenses amounted to ¥146.952 million, up from ¥146.034 million in the previous fiscal year.
  21. FY2020-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥110 million.」

    Cumulative R&D expenses amounted to ¥110 million, roughly the same level as in the same period of the previous year. The disclosure describes ongoing expenditures on R&D activities related to precision metal processing and other areas.
  22. FY2020-Q2Increase in cash outflowsAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year amounted to ¥73.387 million.」

    R&D expenses amounted to ¥73.387 million, up from ¥72.516 million in the same period of the previous year.
  23. FY2020-Q1Decrease in expendituresAnnual report

    「Total R&D expenses for the first three months of the current consolidated fiscal year amounted to ¥36.958 million.」

    R&D expenses amounted to ¥36.958 million, down from the ¥38.504 million reported for the same quarter of the previous year.
  24. FY2019-Q3Increase in cash outflowsAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥110 million.」

    Cumulative R&D expenses amounted to ¥110 million, up from ¥109 million in the same period of the previous year.
  25. FY2019-Q2Increase in cash outflowsAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year amounted to ¥76.448 million.」

    R&D expenses increased from ¥72.516 million in the same period of the previous year to ¥76.448 million.
  26. FY2019-Q1Increase in cash outflowsAnnual report

    「Total R&D expenses for the first three months of the current consolidated fiscal year amounted to ¥38.504 million.」

    R&D expenses increased from ¥34.243 million in the same period of the previous year to ¥38.504 million.
  27. FY2018Increase in cash outflowsAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥146.034 million, with R&D expenses by segment as follows.」

    Full-year R&D expenses amounted to ¥146.034 million, up from ¥132.433 million in the previous fiscal year. The disclosures cover development activities in precision metal processing, molding, assembly and productivity improvement, as well as development for the automotive, medical and housing-equipment markets.
  28. FY2018-Q3Increase in cash outflowsAnnual report

    「Total R&D expenses for the nine-month period ended the third quarter were ¥109 million.」

    Cumulative R&D expenses amounted to ¥109 million, up from ¥72.516 million in the six months ended the second quarter.
  29. FY2018-Q2RestatedAnnual report

    「Total R&D expenses for the six-month period ended the second quarter were ¥72.516 million.」

    Cumulative R&D expenses of ¥72.516 million were disclosed.
  30. FY2018-Q1RestatedAnnual report

    「Total R&D expenses for the three-month period ended the first quarter were ¥34.243 million.」

    R&D expenses related to precision metalworking and other areas totaled ¥34.243 million for the quarter-to-date period.
  31. FY2017RestatedAnnual report

    「The group conducts R&D activities focused on innovations in production technologies, including precision metalworking, forming and assembly, and on further improving productivity. As a result, total R&D expenses for the fiscal year were ¥132.433 million, with R&D expenses by segment as follows.」

    The Company continued R&D activities in precision metalworking, forming, assembly and productivity improvement, and disclosed full-year R&D expenses of ¥132.433 million.
  32. FY2017-Q3Increase in cash outflowsAnnual report

    「Total R&D expenses for the nine-month period ended the third quarter were ¥85 million.」

    Cumulative R&D expenses of ¥85 million were disclosed, up from ¥51.975 million in the second quarter.
  33. FY2017-Q2First statedAnnual report

    「Total R&D expenses for the six-month period ended the second quarter were ¥51.975 million.」

    The Company disclosed total R&D expenses of ¥51.975 million for the six-month period ended the second quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Advanex yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
R&D expenditure | Advanex Inc. (5998) | Komori